NCT04480827 - Open-Label Study to Evaluate the Safety, Tolerability, and PK of Aramchol in Subjects With Hepatic Impairment | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 13, 2020

Primary Completion Date

March 24, 2022

Study Completion Date

March 24, 2022

Conditions

Hepatic Impairment

Interventions

DRUG

Aramchol free acid tablet 600mg, single dose

DRUG

Aramchol free acid tablet 300mg, bid

Aramchol acid tablet 300mg, bid for 12 days

Trial Locations (3)

Orlando Clinical Research Center, Orlando

Division of Clinical Pharmacology, University of Miami, Miami

Alliance for Multispecialty Research, Knoxville